Skip Navigation
Menu
Updates |4 April 2017

Update in Rheumatology: Evidence Published in 2016

E. Blair Solow, MD, MSCS; Shannon A. Scielzo, PhD; Salahuddin Kazi, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
This article was published at Annals.org on 30 March 2017.
  • From the University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.

    Disclosures: Dr. Kazi reports that he serves on the American Board of Internal Medicine Rheumatology Board and is the chair of the American College of Rheumatology's Registries and Health Information Technology Committee. Authors not named here have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-0115.

    Requests for Single Reprints: E. Blair Solow, MD, MSCS, Division of Rheumatic Diseases, Department of Internal Medicine, UT Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Mail Code 8884, Dallas, TX 75390; e-mail, elizabeth.solow@utsouthwestern.edu.

    Current Author Addresses: Drs. Solow, Scielzo, and Kazi: Department of Internal Medicine, UT Southwestern Medical Center at Dallas, 5323 Harry, Hines Boulevard, Dallas, TX 75390.

    Author Contributions: Conception and design: S. Kazi, S.A. Scielzo, E.B. Solow.

    Analysis and interpretation of the data: S. Kazi, S.A. Scielzo, E.B. Solow.

    Drafting of the article: S. Kazi, S.A. Scielzo, E.B. Solow.

    Critical revision for important intellectual content: S. Kazi, E.B. Solow.

    Final approval of the article: S. Kazi, S.A. Scielzo, E.B. Solow.

    Statistical expertise: S.A. Scielzo.

    Collection and assembly of data: S. Kazi, S.A. Scielzo, E.B. Solow.

×
FULL TEXT
In this year's Update in Rheumatology, we review articles within the themes of high-value care, systems-level optimization, risk stratification in patients with autoimmunity, and breakthroughs in treatment strategies. We searched the medical literature by using PubMed and rheumatic disease keywords for the calendar year 2016. We reviewed the abstracts independently and scored the articles on the basis of their relevance to internists and the validity of the methods.
Eight articles are presented in this update, starting with 3 studies on risk stratification in patients with autoimmunity. Nonsteroidal anti-inflammatory drugs (NSAIDs), including celecoxib, are associated with a higher risk for cardiovascular events. Patients with rheumatoid arthritis may have an overall survival benefit from taking a statin. In addition, certain autoimmune conditions may have optimal times to vaccinate for herpes zoster. With regard to systems-level optimization, we discuss how patients may participate in their health care and maintain quality of life while reducing burdens on the medical system, specifically in-person visits. Finally, we address new frontiers in managing rheumatic disease, highlighting innovative medications that target specific proteins in the inflammatory cascade and bone metabolism.
FULL TEXT
PDF
Not Available
Citations
Citation

Solow EB, Scielzo SA, Kazi S. Update in Rheumatology: Evidence Published in 2016. Ann Intern Med. ;166:W44–W47. doi: 10.7326/M17-0115

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2017;166(7):W44-W47.

DOI: 10.7326/M17-0115

Published at www.annals.org on 30 March 2017

©
2017 American College of Physicians
0 Citations

Related Articles
In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding
Annals of Internal Medicine; 167 (4): JC17
Update in Rheumatology: Evidence Published in 2011
Annals of Internal Medicine; 157 (2): 114-119
Evolocumab reduced CV events in patients with atherosclerotic CV disease taking high- or moderate-intensity statins
Annals of Internal Medicine; 167 (2): JC7
In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years
Annals of Internal Medicine; 166 (2): JC5
View MoreView Less

Journal Club
In high-risk patients with arthritis and previous upper GI bleeding, celecoxib vs naproxen reduced recurrent bleeding
Annals of Internal Medicine; 167 (4): JC17
Evolocumab reduced CV events in patients with atherosclerotic CV disease taking high- or moderate-intensity statins
Annals of Internal Medicine; 167 (2): JC7
In adults ≥ 70 years of age, an adjuvanted herpes zoster subunit vaccine reduced herpes zoster at a mean 3.7 years
Annals of Internal Medicine; 166 (2): JC5
ACC/AHA Pooled Cohort Risk Equations predicted 5-y risk for CV events in adults considered for statin initiation
Annals of Internal Medicine; 161 (4): JC12
View MoreView Less

Related Point of Care
Herpes Zoster
Annals of Internal Medicine; 169 (3): ITC17-ITC32
Herpes Zoster
Annals of Internal Medicine; 154 (5): ITC3-1
Osteoarthritis
Annals of Internal Medicine; 147 (3): ITC8-1
Rheumatoid Arthritis
Annals of Internal Medicine; 153 (1): ITC1-1
View MoreView Less

Related Topics
Lupus Erythematosus
Rheumatology
Updates

Lupus Erythematosus, Rheumatology, Updates.

PubMed Articles
Chemerin-activated functions of CMKLR1 are regulated by G protein-coupled receptor kinase 6 (GRK6) and β-arrestin 2 in inflammatory macrophages.
Mol Immunol 2018;
Non-target metabonomic method provided new insights on the therapeutical mechanism of Gancao Fuzi decoction on rheumatoid arthritis rats.
J Chromatogr B Analyt Technol Biomed Life Sci 2018;
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×